Recall
FDAHealthJune 2, 2025

Tailstorm Health INC — KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-Dose Vial, Rx Only, For Office Use Only, Compounded Drug by: Medivant Healt

⚠️ Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 2, 2025

Nationwide in the US

What's affected?

Product
KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-Dose Vial, Rx Only, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene, Rd. Chandler, AZ 85226, NDC 81483-0007-2.
Lot code
2502009

Additional details

Lot: 2502009, Exp. 3/2/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 14,725 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.